Advertisement

Trends in patient procurement of postoperative opioids and route of hysterectomy in the United States from 2004 through 2014

      Background

      The opioid epidemic in the United States is a public health emergency. Minimally invasive surgical technology has decreased length of hospital stay, improved postoperative recovery, and decreased postoperative pain. Hysterectomy is one of the most commonly performed surgeries in the United States. Increasing trends in minimally invasive gynecologic surgery are expected to reduce patients’ postoperative pain. It is unclear whether this assumption has resulted in decreasing postoperative opioid prescriptions or patient need for these prescriptions, as prescribing patterns may be contributing to the current opioid public health emergency.

      Objective

      We sought to describe opioid prescribing and patient procurement practices for postoperative pain at time of discharge for benign hysterectomy from 2004 through 2014 using the Truven Health Analytics MarketScan Research Database. The trends of the route of hysterectomy over this time period were concomitantly described to reflect the movement toward more minimally invasive approaches.

      Study Design

      The Truven Health Analytics MarketScan Research Database including the Commercial Claims and Encounters Database, and the Medicare Supplemental and Coordination of Benefits Database were utilized. Current Procedural Terminology, 4th Edition, and International Classification of Diseases, Ninth Revision, codes identified all patients who underwent a hysterectomy for benign indications from 2004 through 2014. Hysterectomy routes were categorized into abdominal, laparoscopic, and vaginal. The MarketScan database captures prescriptions filled at a retail or mail-order pharmacy and does not capture prescriptions filled within the inpatient, hospital facility. The days of opioids procured by patients at the time of discharge were identified for each encounter. Descriptive statistics were used to summarize data within the entire study period. Although this article is purely descriptive, further analyses were conducted for exploratory purposes only. analysis of variance and χ2 analyses were used for continuous and categorical variables, respectively. Multiple linear regression models were used to describe associations between variables of interest and postoperative opioid prescriptions.

      Results

      We identified 793,016 patients who underwent a hysterectomy for benign indications from 2004 through 2014. Of these, 96% were identified from the Commercial Claims and Encounters Database. During the study period, the overall route of hysterectomy was categorized into 40.5% abdominal, 42.0% laparoscopic, and 17.5% vaginal hysterectomy. The route of hysterectomy changed from 60.2–25.6% (a decrease of Δ = 34.58; 95% confidence interval, 33.96–35.20) for abdominal, 17.0–61.9% (an increase of Δ = 44.83; 95% confidence interval, 44.21–45.44) for laparoscopic, and 22.8–12.6% (a decrease of Δ = 10.25; 95% confidence interval, 9.77–10.73) for vaginal. At discharge, the percentage of patients who were prescribed opioids and filled them increased from 25.6–82.1% (an increase of Δ = 56.50; 95% confidence interval, 55.88–57.13 with P < .001) from 2004 through 2014 for all hysterectomy routes. Additionally, the quantity of opioids prescribed also increased.

      Conclusion

      Opioid prescriptions filled for postoperative pain after hysterectomy substantially increased from 2004 through 2014. Opioid prescription procurement has increased despite a concomitant increase in minimally invasive hysterectomy routes. In light of the current opioid epidemic, physicians must recognize that postoperative prescribing practices may contribute to chronic opioid use. Heightened awareness of opioid prescribing practices following surgery is critically important to decrease risk of development of chronic opioid dependence.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gostin L.O.
        • Hodge J.G.
        • Noe S.A.
        Reframing the opioid epidemic as a national emergency.
        JAMA. 2017; 318: 1539-1540
        • Frasco P.E.
        • Sprung J.
        • Trentman T.L.
        The impact of the joint commission for accreditation of healthcare organizations pain initiative on perioperative opiate consumption and recovery room length of stay.
        Anesth Analg. 2005; 100: 162-168
        • Mularski R.A.
        • White-Chu F.
        • Overbay D.
        • et al.
        Measuring pain as the 5th vital sign does not improve quality of pain management.
        J Gen Intern Med. 2006; 21: 607-612
        • Manchikanti L.
        • Helm S.
        • Fellows B.
        • et al.
        Opioid epidemic in the United States.
        Pain Physician. 2012; 15 (ES9-38)
        • Baker D.W.
        History of the Joint Commission's pain standards: lessons for today's prescription opioid epidemic.
        JAMA. 2017; 317: 1117-1118
        • Manchikanti L.
        • Singh A.
        Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
        Pain Physician. 2008; 11: S63-S88
      1. Department of Health and Human Services. The opioid epidemic: by the numbers, in CDC National Vital Statistics System. Available at: http://www.hhs.gov/opioids. Accessed December 2017.

        • Rudd R.A.
        • Seth P.
        • David F.
        • et al.
        Increases in drug and opioid-involved overdose deaths–United States, 2010-2015.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1445-1452
        • Centers for Disease Control and Prevention
        Vital signs: overdoses of prescription opioid pain relievers–United States, 1999-2008.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 1487-1492
        • Alam A.
        • Gomes T.
        • Zheng H.
        • et al.
        Long-term analgesic use after low-risk surgery: a retrospective cohort study.
        Arch Intern Med. 2012; 172: 425-430
        • Clarke H.
        • Soneji N.
        • Ko D.T.
        • et al.
        Rates and risk factors for prolonged opioid use after major surgery: population based cohort study.
        BMJ. 2014; 348: g1251
        • Sun E.C.
        • Darnall B.D.
        • Baker L.C.
        • et al.
        Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period.
        JAMA Intern Med. 2016; 176: 1286-1293
        • Shah A.
        • Hayes C.J.
        • Martin B.C.
        Characteristics of initial prescription episodes and likelihood of long-term opioid use–United States, 2006-2015.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 265-269
        • Cohen S.L.
        • Vitonis A.F.
        • Einarsson J.I.
        Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy.
        JSLS. 2014; 18
        • Wright J.D.
        • Herzog T.J.
        • Tsui J.
        • et al.
        Nationwide trends in the performance of inpatient hysterectomy in the United States.
        Obstet Gynecol. 2013; 122: 233-241
        • Aarts J.W.M.
        • Nieboer T.E.
        • Johson N.
        • et al.
        Surgical approach to hysterectomy for benign gynecological disease.
        Cochrane Database Syst Rev. 2015; 8: CD003677
        • Wu J.M.
        • Wechter M.E.
        • Geller E.J.
        • et al.
        Hysterectomy rates in the United States, 2003.
        Obstet Gynecol. 2007; 110: 1091-1095
        • Quint J.B.
        Health research data for the real world: the MarketScan databases.
        Truven Health Analytics, Ann Arbor, MI2015
      2. US Census Bureau. United States Census 2010. Available at: https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf. Accessed Dec. 1, 2017.

        • Tehrani A.B.
        • Henke R.M.
        • Ali M.M.
        • et al.
        Trends in average days' supply of opioid medications in Medicaid and commercial insurance.
        Addict Behav. 2018; 76: 218-222
        • Ben-Joseph R.
        • Bell J.A.
        • Brixner D.
        • et al.
        Opioid treatment patterns following prescription of immediate-release hydrocodone.
        J Manag Care Spec Pharm. 2016; 22: 358-366
        • Marziarani M.
        Heteroscedastic and homoscedastic GLMM and GLM: application to effort estimation in the Gulf of Mexico shrimp fishery, 1984 through 2001.
        Int J Prob Stat. 2018; 7: 19-30
        • Barkley A.
        Evaluating goodness-of-fit for a logistic regression model using the Hosmer-Lemeshow test on samples from a large data set.
        (Available at:) (Accessed May 2018)
        • Kramer A.A.
        • Zimmerman J.E.
        Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited.
        Crit Care Med. 2007; 35: 2052-2056
        • Paul P.
        • Pennell M.L.
        • Lemeshow S.
        Standardizing the power of the Hosmer–Lemeshow goodness of fit test in large data sets.
        Stat Med. 2013; 32: 67-80
        • Brat G.A.
        • Agniel D.
        • Beam A.
        • et al.
        Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study.
        BMJ. 2018; 360: j5790
        • Chen E.Y.
        • Marcantonio A.
        • Tornetta III, P.
        Correlation between 24-hour predischarge opioid use and amount of opioids prescribed at hospital discharge.
        JAMA Surg. 2018; 153: e174859
        • Baker J.A.
        • Avorn J.
        • Levin R.
        • et al.
        Opioid prescribing after surgical extraction of teeth in Medicaid patients, 2000-2010.
        JAMA. 2016; 315: 1653-1654
        • Hill M.V.
        • McMahon M.L.
        • Stucke R.S.
        • et al.
        Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures.
        Ann Surg. 2017; 265: 709-714
        • Swenson C.W.
        • Kelley A.S.
        • Fenner D.E.
        • et al.
        Outpatient narcotic use after minimally-invasive urogynecologic surgery.
        Female Pelvic Med Reconstr Surg. 2016; 22: 377-381
        • Bates C.
        • Laciak R.
        • Southwick A.
        • et al.
        Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice.
        J Urol. 2011; 185: 551-555
        • Hill M.V.
        • Stucke R.S.
        • Billmeier S.E.
        • et al.
        Guideline for discharge opioid prescriptions after inpatient general surgical procedures.
        J Am Coll Surg. 2018; 226: 996-1003
        • Campbell C.I.
        • Weisner C.
        • Leresche L.
        • et al.
        Age and gender trends in long-term opioid analgesic use for noncancer pain.
        Am J Public Health. 2010; 100: 2541-2547
        • Centers for Disease Control and Prevention
        Vital signs: overdoses of prescription opioid pain relievers and other drugs among women–United States, 1999-2010.
        MMWR Morb Mortal Wkly Rep. 2013; 62: 537-542
        • ACOG
        Choosing the route of hysterectomy for benign disease. Committee opinion no. 444.
        Obstet Gynecol. 2009; 114: 1156-1158
        • Pedersen C.A.
        • Schneider P.J.
        • Scheckelhoff D.J.
        ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing–2016.
        Am J Health Syst Pharm. 2017; 74: 1336-1352

      Linked Article